Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger HIT domain-containing protein 1 (ZNHIT1) is an evolutionarily conserved chromatin remodeler and subunit of the SRCAP complex, which regulates gene expression by promoting the incorporation of the histone variant H2A.Z at specific genomic sites. It is essential for maintaining quiescence and lineage commitment in hematopoietic stem cells, controlling the fate and homeostasis of intestinal and other tissue stem cells, and facilitating the appropriate expression of genes involved in muscle differentiation, neurogenesis, germ cell meiosis, and the DNA damage response. Loss of ZNHIT1 disrupts tissue homeostasis and has been linked to impaired organ development, stem cell exhaustion, developmental syndromes, and cancer-related processes, but it is not presently considered a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger HIT domain-containing protein 1 (ZNHIT1).